AMERIPRISE FINANCIAL INC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$149,625
-73.8%
13,300
-73.1%
0.00%
Q1 2023$570,367
+112.0%
49,511
+113.2%
0.00%
Q4 2022$269,000
-8.8%
23,2200.0%0.00%
Q3 2022$295,00023,2200.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders